Need [qlco]
Therapies, Combination Drug [topp]
Patients [podg]
Complex [qlco]
Dyslipidaemia [dsyn]
Statins [orch, phsu]
First-Line Therapy [topp]
Prevention [topp]
Cardiovascular disease [dsyn]
High Risk [qlco]
Patients [podg]
Standard [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Target [ftcn]
Patients [podg]
Familial hypercholesterolaemia [dsyn]
GENETIC [topp]
Mixed hyperlipidemia [dsyn]
Meet [idcn]
Goals [inpr]
standard therapy [topp]
Patients [podg]
Mixed hyperlipidaemia [dsyn]
secondary [neop]
Metabolic syndrome [dsyn]
Diabetes [dsyn]
Renal [bpoc]
HIV infection [dsyn]
High Risk [qlco]
Residual [qlco]
Low HDL-cholesterol [fndg]
high triglycerides [fndg]
new therapy [idcn]
Added [ftcn]
Statins [orch, phsu]
ezetimibe [orch, phsu]
CARDIOVASCULAR [bdsy]
Disease Outcome [fndg]
Chronic Renal Disease [dsyn]
ADD [mobd]
Omega-3 Fatty Acids [bacs, lipd, phsu]
Fibrates [orch, phsu]
Niacin [orch, phsu, vita]
Statins [orch, phsu]
Failed [ftcn]
Benefit [qnco]
Possibly [qlco]
Fibrates [orch, phsu]
Patients [podg]
Diabetes [dsyn]
low hdl [fndg]
high triglycerides [fndg]
Additional [ftcn]
Benefits [qnco]
Lipid [lipd]
Profile [lbpr]
pro subtilisin [aapp, enzy]
Protein [aapp, bacs]
kexin [aapp, enzy]
mipomersen [nnon, phsu]
lomitapide [orch, phsu]
Cholesterol ester transfer protein [aapp, bacs]
inhibitors [chvf]
Cholesterol ester transfer protein [aapp, bacs]
inhibitors [chvf]
Failed [ftcn]
Benefit [qnco]
Hard [qlco]
Trial [resa]
Others [fndg]
Investigation [hlca]
Additional Therapy [fndg]
ADD [mobd]
Statins [orch, phsu]
Prevention [topp]
Cardiovascular disease [dsyn]
Patients [podg]
Added [ftcn]
Benefit [qnco]
Patients [podg]
Complex [qlco]
Dyslipidemias [dsyn]
